세계의 불안장애 및 우울증 치료 시장 규모, 점유율, 동향 분석 : 적응증별, 약제별, 유통 채널별, 지역별 전망과 예측(2024-2031년)
Global Anxiety Disorders And Depression Treatment Market Size, Share & Trends Analysis Report By Indication (Anxiety and Depression) By Drugs, By Distribution Channel, By Regional Outlook and Forecast, 2024 - 2031
상품코드:1539122
리서치사:KBV Research
발행일:2024년 08월
페이지 정보:영문 259 Pages
라이선스 & 가격 (부가세 별도)
한글목차
불안장애/우울증 치료 시장 규모는 예측 기간 중 3.5%의 CAGR로 시장 성장하며, 2031년까지 157억 달러에 달할 것으로 예상되고 있습니다.
또한 이러한 증상을 경험하는 사람들의 수가 증가함에 따라 약물치료, 심리치료 및 기타 치료적 개입을 포함한 효과적인 치료법에 대한 수요가 크게 증가했습니다. 불안장애/우울증 치료를 찾는 사람들이 늘어남에 따라 치료 시장은 계속 확대되고 있습니다.
그러나 불안장애와 우울증에 대한 첨단 치료와 요법은 고가의 비용이 들기 때문에 많은 사람들이 치료를 받지 못하는 경우가 있습니다. 모든 사람이 이러한 치료를 받을 수 있는 충분한 재정적 자원이나 종합적인 보험을 가지고 있는 것은 아닙니다. 그 결과, 첨단 치료가 필요한 사람들은 치료를 포기하거나 덜 효과적인 대체 요법을 선택하게 되고, 이는 건강 상태에 악영향을 미칠 수 있습니다.
적응증 전망
적응증에 따라 시장은 우울증과 불안장애로 분류됩니다. 불안장애 부문은 2023년 시장에서 55%의 매출 점유율을 기록했습니다. 불안장애는 전 세계에서 가장 흔한 정신 질환 중 하나입니다. 범불안장애(GAD), 공황장애, 사회불안장애와 같은 질환은 수백만 명의 사람들에게 영향을 미치며 효과적인 치료법에 대한 큰 수요를 창출하고 있습니다.
약제 전망
약물을 기준으로 시장은 항우울제, 항불안제, 항경련제, 노르아드레날린 작용제, 비정형 항정신병 약물로 분류됩니다. 비정형 항 정신병 약물 부문은 2023년 시장에서 24%의 매출 점유율을 차지했습니다. 비정형 항 정신병 약은 우울증과 불안장애의 증상, 과민성 및 기분 변화와 같은 다른 증상을 관리하는 데 도움이 됩니다.
유통 채널 전망
유통 채널별로 보면 시장은 소매 약국, 병원 약국, 온라인 약국으로 나뉘며, 2023년 소매 약국 부문은 시장에서 55%의 매출 점유율을 기록했습니다. 소매 약국은 접근성이 뛰어나기 때문에 환자는 전문 클리닉이나 병원에 가지 않고도 쉽게 약을 구할 수 있습니다.
지역 전망
지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카에서 시장을 분석했으며, 2023년에는 아시아태평양이 시장에서 26%의 매출 점유율을 차지할 것으로 예상됩니다. 아시아태평양 전체에서 정신건강 문제에 대한 인식이 높아지고 있습니다.
목차
제1장 시장 범위와 조사 방법
시장의 정의
목적
시장 범위
세분화
조사 방법
제2장 시장 개관
주요 하이라이트
제3장 시장 개요
서론
개요
시장 구성과 시나리오
시장에 영향을 미치는 주요 요인
시장 성장 촉진요인
시장 성장 억제요인
시장 기회
시장이 해결해야 할 과제
Porter's Five Forces 분석
제4장 세계 시장 : 적응증별
세계의 불안장애 시장 : 지역별
세계의 우울증 시장 : 지역별
제5장 세계 시장 : 약제별
세계의 항우울제 시장 : 지역별
세계의 항불안약시장 : 지역별
세계의 항경련약 시장 : 지역별
세계의 노르아드레날린 작용제 시장 : 지역별
세계의 비정형항정신병약 시장 : 지역별
제6장 세계 시장 : 유통 채널별
세계의 소매 약국 시장 : 지역별
세계의 병원 약국 시장 : 지역별
세계의 온라인 약국 시장 : 지역별
제7장 세계 시장 : 지역별
북미
북미의 시장 : 국가별
미국
캐나다
멕시코
기타 북미 지역
유럽
유럽의 시장 : 국가별
독일
영국
프랑스
러시아
스페인
이탈리아
기타 유럽 지역
아시아태평양
아시아태평양의 시장 : 국가별
중국
일본
인도
한국
싱가포르
말레이시아
기타 아시아태평양
라틴아메리카·중동 및 아프리카
라틴아메리카·중동 및 아프리카의 시장 : 국가별
브라질
아르헨티나
아랍에미리트
사우디아라비아
남아프리카공화국
나이지리아
기타 라틴아메리카·중동 및 아프리카 지역
제8장 기업 개요
Pfizer, Inc
GlaxoSmithKline PLC(GSK)
Merck & Co, Inc.
Eli Lilly And Company
AstraZeneca PLC
Bristol-Myers Squibb Company
Johnson & Johnson
AbbVie, Inc
Sanofi SA
Takeda Pharmaceutical Company Limited
제9장 불안장애/우울증 치료 시장의 성공 필수 조건
KSA
영문 목차
영문목차
The Global Anxiety Disorders And Depression Treatment Market size is expected to reach $15.7 billion by 2031, rising at a market growth of 3.5% CAGR during the forecast period.
Anticonvulsants have been shown to help manage comorbid anxiety symptoms in patients with mood disorders. Their ability to address multiple aspects of a patient's condition makes them a valuable treatment option. Lower Risk of Traditional Antidepressant Side Effects: Some anticonvulsants have a more favourable side effect profile compared to certain antidepressants, particularly concerning issues like sexual dysfunction or weight gain, making them a preferred choice for some patients. Thus, the Anticonvulsants segment attained 6% revenue share in the market in 2023.
The increasing emphasis on preventive care and early intervention has significantly impacted the anxiety disorders and depression treatment market. By identifying mental health issues at an earlier stage, healthcare providers can initiate treatment before the conditions become severe.
Additionally, the growing number of individuals experiencing these conditions has created a significant demand for effective treatments, including medications, psychotherapy, and other therapeutic interventions. As more people seek help for anxiety and depression, the market for treatments continues to expand.
However, the high cost of advanced treatments and therapies for anxiety disorders and depression can limit access to care for many individuals. Not everyone has sufficient financial resources or comprehensive insurance coverage to afford these treatments. As a result, people who need advanced therapies may forego treatment or opt for less effective alternatives, which can negatively impact their health outcomes.
Indication Outlook
On the basis of indication, the market is segmented into depression and anxiety. The anxiety segment recorded 55% revenue share in the market in 2023. Anxiety disorders are among the most common mental health conditions globally. Conditions such as generalized anxiety disorder (GAD), panic disorder, and social anxiety disorder affect millions of people, driving significant demand for effective treatments.
Drug Outlook
Based on drugs, the market are divided into antidepressants, anxiolytics, anticonvulsants, noradrenergic agents, atypical antipsychotics. The atypical antipsychotics segment procured 24% revenue share in the market in 2023. Atypical antipsychotics can help manage both depressive and anxiety symptoms, as well as other symptoms like irritability and mood swings.
Distribution Channel Outlook
By distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, and online pharmacies. In 2023, the retail pharmacies segment registered 55% revenue share in the market. Retail pharmacies are widely accessible, making it easy for patients to obtain their medications without visiting specialized clinics or hospitals.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated 26% revenue share in the market. There has been a growing awareness and recognition of mental health issues across the Asia-Pacific region.
List of Key Companies Profiled
Pfizer Inc.
GlaxoSmithKline PLC (GSK)
Merck & Co., Inc.
Eli Lilly And Company
AstraZeneca PLC
Bristol-Myers Squibb Company
Johnson & Johnson
AbbVie Inc.
Sanofi S.A.
Takeda Pharmaceutical Company Limited
Global Anxiety Disorders And Depression Treatment Market Report Segmentation
By Indication
Anxiety
Depression
By Drugs
Antidepressants
Anxiolytics
Anticonvulsants
Noradrenergic Agents
Atypical Antipsychotics
By Distribution Channel
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Geography
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Anxiety Disorders And Depression Treatment Market, by Indication
1.4.2 Global Anxiety Disorders And Depression Treatment Market, by Drugs
1.4.3 Global Anxiety Disorders And Depression Treatment Market, by Distribution Channel
1.4.4 Global Anxiety Disorders And Depression Treatment Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Global Anxiety Disorders And Depression Treatment Market by Indication
4.1 Global Anxiety Market by Region
4.2 Global Depression Market by Region
Chapter 5. Global Anxiety Disorders And Depression Treatment Market by Drugs
5.1 Global Antidepressants Market by Region
5.2 Global Anxiolytics Market by Region
5.3 Global Anticonvulsants Market by Region
5.4 Global Noradrenergic Agents Market by Region
5.5 Global Atypical Antipsychotics Market by Region
Chapter 6. Global Anxiety Disorders And Depression Treatment Market by Distribution Channel
6.1 Global Retail Pharmacies Market by Region
6.2 Global Hospital Pharmacies Market by Region
6.3 Global Online Pharmacies Market by Region
Chapter 7. Global Anxiety Disorders And Depression Treatment Market by Region
7.1 North America Anxiety Disorders And Depression Treatment Market
7.1.1 North America Anxiety Disorders And Depression Treatment Market by Indication
7.1.1.1 North America Anxiety Market by Country
7.1.1.2 North America Depression Market by Country
7.1.2 North America Anxiety Disorders And Depression Treatment Market by Drugs
7.1.2.1 North America Antidepressants Market by Country
7.1.2.2 North America Anxiolytics Market by Country
7.1.2.3 North America Anticonvulsants Market by Country
7.1.2.4 North America Noradrenergic Agents Market by Country
7.1.2.5 North America Atypical Antipsychotics Market by Country
7.1.3 North America Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.1.3.1 North America Retail Pharmacies Market by Country
7.1.3.2 North America Hospital Pharmacies Market by Country
7.1.3.3 North America Online Pharmacies Market by Country
7.1.4 North America Anxiety Disorders And Depression Treatment Market by Country
7.1.4.1 US Anxiety Disorders And Depression Treatment Market
7.1.4.1.1 US Anxiety Disorders And Depression Treatment Market by Indication
7.1.4.1.2 US Anxiety Disorders And Depression Treatment Market by Drugs
7.1.4.1.3 US Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.1.4.2 Canada Anxiety Disorders And Depression Treatment Market
7.1.4.2.1 Canada Anxiety Disorders And Depression Treatment Market by Indication
7.1.4.2.2 Canada Anxiety Disorders And Depression Treatment Market by Drugs
7.1.4.2.3 Canada Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.1.4.3 Mexico Anxiety Disorders And Depression Treatment Market
7.1.4.3.1 Mexico Anxiety Disorders And Depression Treatment Market by Indication
7.1.4.3.2 Mexico Anxiety Disorders And Depression Treatment Market by Drugs
7.1.4.3.3 Mexico Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.1.4.4 Rest of North America Anxiety Disorders And Depression Treatment Market
7.1.4.4.1 Rest of North America Anxiety Disorders And Depression Treatment Market by Indication
7.1.4.4.2 Rest of North America Anxiety Disorders And Depression Treatment Market by Drugs
7.1.4.4.3 Rest of North America Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.2 Europe Anxiety Disorders And Depression Treatment Market
7.2.1 Europe Anxiety Disorders And Depression Treatment Market by Indication
7.2.1.1 Europe Anxiety Market by Country
7.2.1.2 Europe Depression Market by Country
7.2.2 Europe Anxiety Disorders And Depression Treatment Market by Drugs
7.2.2.1 Europe Antidepressants Market by Country
7.2.2.2 Europe Anxiolytics Market by Country
7.2.2.3 Europe Anticonvulsants Market by Country
7.2.2.4 Europe Noradrenergic Agents Market by Country
7.2.2.5 Europe Atypical Antipsychotics Market by Country
7.2.3 Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.2.3.1 Europe Retail Pharmacies Market by Country
7.2.3.2 Europe Hospital Pharmacies Market by Country
7.2.3.3 Europe Online Pharmacies Market by Country
7.2.4 Europe Anxiety Disorders And Depression Treatment Market by Country
7.2.4.1 Germany Anxiety Disorders And Depression Treatment Market
7.2.4.1.1 Germany Anxiety Disorders And Depression Treatment Market by Indication
7.2.4.1.2 Germany Anxiety Disorders And Depression Treatment Market by Drugs
7.2.4.1.3 Germany Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.2.4.2 UK Anxiety Disorders And Depression Treatment Market
7.2.4.2.1 UK Anxiety Disorders And Depression Treatment Market by Indication
7.2.4.2.2 UK Anxiety Disorders And Depression Treatment Market by Drugs
7.2.4.2.3 UK Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.2.4.3 France Anxiety Disorders And Depression Treatment Market
7.2.4.3.1 France Anxiety Disorders And Depression Treatment Market by Indication
7.2.4.3.2 France Anxiety Disorders And Depression Treatment Market by Drugs
7.2.4.3.3 France Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.2.4.4 Russia Anxiety Disorders And Depression Treatment Market
7.2.4.4.1 Russia Anxiety Disorders And Depression Treatment Market by Indication
7.2.4.4.2 Russia Anxiety Disorders And Depression Treatment Market by Drugs
7.2.4.4.3 Russia Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.2.4.5 Spain Anxiety Disorders And Depression Treatment Market
7.2.4.5.1 Spain Anxiety Disorders And Depression Treatment Market by Indication
7.2.4.5.2 Spain Anxiety Disorders And Depression Treatment Market by Drugs
7.2.4.5.3 Spain Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.2.4.6 Italy Anxiety Disorders And Depression Treatment Market
7.2.4.6.1 Italy Anxiety Disorders And Depression Treatment Market by Indication
7.2.4.6.2 Italy Anxiety Disorders And Depression Treatment Market by Drugs
7.2.4.6.3 Italy Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.2.4.7 Rest of Europe Anxiety Disorders And Depression Treatment Market
7.2.4.7.1 Rest of Europe Anxiety Disorders And Depression Treatment Market by Indication
7.2.4.7.2 Rest of Europe Anxiety Disorders And Depression Treatment Market by Drugs
7.2.4.7.3 Rest of Europe Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.3 Asia Pacific Anxiety Disorders And Depression Treatment Market
7.3.1 Asia Pacific Anxiety Disorders And Depression Treatment Market by Indication
7.3.1.1 Asia Pacific Anxiety Market by Country
7.3.1.2 Asia Pacific Depression Market by Country
7.3.2 Asia Pacific Anxiety Disorders And Depression Treatment Market by Drugs
7.3.2.1 Asia Pacific Antidepressants Market by Country
7.3.2.2 Asia Pacific Anxiolytics Market by Country
7.3.2.3 Asia Pacific Anticonvulsants Market by Country
7.3.2.4 Asia Pacific Noradrenergic Agents Market by Country
7.3.2.5 Asia Pacific Atypical Antipsychotics Market by Country
7.3.3 Asia Pacific Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.3.3.1 Asia Pacific Retail Pharmacies Market by Country
7.3.3.2 Asia Pacific Hospital Pharmacies Market by Country
7.3.3.3 Asia Pacific Online Pharmacies Market by Country
7.3.4 Asia Pacific Anxiety Disorders And Depression Treatment Market by Country
7.3.4.1 China Anxiety Disorders And Depression Treatment Market
7.3.4.1.1 China Anxiety Disorders And Depression Treatment Market by Indication
7.3.4.1.2 China Anxiety Disorders And Depression Treatment Market by Drugs
7.3.4.1.3 China Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.3.4.2 Japan Anxiety Disorders And Depression Treatment Market
7.3.4.2.1 Japan Anxiety Disorders And Depression Treatment Market by Indication
7.3.4.2.2 Japan Anxiety Disorders And Depression Treatment Market by Drugs
7.3.4.2.3 Japan Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.3.4.3 India Anxiety Disorders And Depression Treatment Market
7.3.4.3.1 India Anxiety Disorders And Depression Treatment Market by Indication
7.3.4.3.2 India Anxiety Disorders And Depression Treatment Market by Drugs
7.3.4.3.3 India Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.3.4.4 South Korea Anxiety Disorders And Depression Treatment Market
7.3.4.4.1 South Korea Anxiety Disorders And Depression Treatment Market by Indication
7.3.4.4.2 South Korea Anxiety Disorders And Depression Treatment Market by Drugs
7.3.4.4.3 South Korea Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.3.4.5 Singapore Anxiety Disorders And Depression Treatment Market
7.3.4.5.1 Singapore Anxiety Disorders And Depression Treatment Market by Indication
7.3.4.5.2 Singapore Anxiety Disorders And Depression Treatment Market by Drugs
7.3.4.5.3 Singapore Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.3.4.6 Malaysia Anxiety Disorders And Depression Treatment Market
7.3.4.6.1 Malaysia Anxiety Disorders And Depression Treatment Market by Indication
7.3.4.6.2 Malaysia Anxiety Disorders And Depression Treatment Market by Drugs
7.3.4.6.3 Malaysia Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.3.4.7 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market
7.3.4.7.1 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market by Indication
7.3.4.7.2 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market by Drugs
7.3.4.7.3 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.4 LAMEA Anxiety Disorders And Depression Treatment Market
7.4.1 LAMEA Anxiety Disorders And Depression Treatment Market by Indication
7.4.1.1 LAMEA Anxiety Market by Country
7.4.1.2 LAMEA Depression Market by Country
7.4.2 LAMEA Anxiety Disorders And Depression Treatment Market by Drugs
7.4.2.1 LAMEA Antidepressants Market by Country
7.4.2.2 LAMEA Anxiolytics Market by Country
7.4.2.3 LAMEA Anticonvulsants Market by Country
7.4.2.4 LAMEA Noradrenergic Agents Market by Country
7.4.2.5 LAMEA Atypical Antipsychotics Market by Country
7.4.3 LAMEA Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.4.3.1 LAMEA Retail Pharmacies Market by Country
7.4.3.2 LAMEA Hospital Pharmacies Market by Country
7.4.3.3 LAMEA Online Pharmacies Market by Country
7.4.4 LAMEA Anxiety Disorders And Depression Treatment Market by Country
7.4.4.1 Brazil Anxiety Disorders And Depression Treatment Market
7.4.4.1.1 Brazil Anxiety Disorders And Depression Treatment Market by Indication
7.4.4.1.2 Brazil Anxiety Disorders And Depression Treatment Market by Drugs
7.4.4.1.3 Brazil Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.4.4.2 Argentina Anxiety Disorders And Depression Treatment Market
7.4.4.2.1 Argentina Anxiety Disorders And Depression Treatment Market by Indication
7.4.4.2.2 Argentina Anxiety Disorders And Depression Treatment Market by Drugs
7.4.4.2.3 Argentina Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.4.4.3 UAE Anxiety Disorders And Depression Treatment Market
7.4.4.3.1 UAE Anxiety Disorders And Depression Treatment Market by Indication
7.4.4.3.2 UAE Anxiety Disorders And Depression Treatment Market by Drugs
7.4.4.3.3 UAE Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.4.4.4 Saudi Arabia Anxiety Disorders And Depression Treatment Market
7.4.4.4.1 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Indication
7.4.4.4.2 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Drugs
7.4.4.4.3 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.4.4.5 South Africa Anxiety Disorders And Depression Treatment Market
7.4.4.5.1 South Africa Anxiety Disorders And Depression Treatment Market by Indication
7.4.4.5.2 South Africa Anxiety Disorders And Depression Treatment Market by Drugs
7.4.4.5.3 South Africa Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.4.4.6 Nigeria Anxiety Disorders And Depression Treatment Market
7.4.4.6.1 Nigeria Anxiety Disorders And Depression Treatment Market by Indication
7.4.4.6.2 Nigeria Anxiety Disorders And Depression Treatment Market by Drugs
7.4.4.6.3 Nigeria Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.4.4.7 Rest of LAMEA Anxiety Disorders And Depression Treatment Market
7.4.4.7.1 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Indication
7.4.4.7.2 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Drugs
7.4.4.7.3 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Pfizer, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 GlaxoSmithKline PLC (GSK)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Merck & Co., Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 Eli Lilly And Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 AstraZeneca PLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Bristol-Myers Squibb Company
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Johnson & Johnson
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental & Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 AbbVie, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Sanofi S.A.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Takeda Pharmaceutical Company Limited
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis
Chapter 9. Winning Imperatives for Anxiety Disorders and Depression Treatment Market
